midazolam has been researched along with oxymorphone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doze, VA; Shafer, A; Urquhart, ML; White, PF | 1 |
| Jacobson, JD; McGrath, CJ; Smith, EP | 1 |
| Aronsohn, MG; Faggella, AM | 1 |
| Adams, M; Ahdieh, H; Gammaitoni, AR; Pieniaszek, HJ | 1 |
1 review(s) available for midazolam and oxymorphone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for midazolam and oxymorphone
| Article | Year |
|---|---|
Outpatient premedication: use of midazolam and opioid analgesics.
Topics: Adult; Ambulatory Surgical Procedures; Double-Blind Method; Drug Combinations; Female; Fentanyl; Humans; Hydromorphone; Intraoperative Period; Male; Midazolam; Oxymorphone; Preanesthetic Medication; Randomized Controlled Trials as Topic | 1989 |
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways.
Topics: Adolescent; Adult; Analgesics, Opioid; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Interactions; Erythromycin; Female; Humans; Male; Midazolam; Middle Aged; Naltrexone; Oxymorphone; Rifampin; Tolbutamide | 2005 |
5 other study(ies) available for midazolam and oxymorphone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Cardiorespiratory effects of induction and maintenance of anesthesia with ketamine-midazolam combination, with and without prior administration of butorphanol or oxymorphone.
Topics: Anesthesia, Intravenous; Animals; Butorphanol; Dogs; Drug Interactions; Heart; Hemodynamics; Ketamine; Male; Midazolam; Oxymorphone; Respiration | 1994 |
Anesthetic techniques for neutering 6- to 14-week-old kittens.
Topics: Analgesia; Anesthesia; Animals; Butorphanol; Castration; Cats; Drug Combinations; Female; Heart Rate; Ketamine; Male; Midazolam; Oxymorphone; Preanesthetic Medication; Random Allocation; Respiration; Tiletamine; Zolazepam | 1993 |